Unfortunately we have to be patient.
MSB are reliant on other parties:
Rely on NIH providing the stats
Rely on the FDA booking in a meeting time, and hopefully being more forward thinking and trusting experts this time
Rely on big companies deciding to partner / fund MSB
MSB alone cannot make this happen, I imagine they would love to have this sorted out already.
No advice, although more patience by me would be helpful.
Ann: Mesoblast Operational Highlights and Upcoming Milestones, page-33
-
- There are more pages in this discussion • 145 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
97.3¢ |
Change
0.013(1.30%) |
Mkt cap ! $1.118B | |||
| Open | High | Low | Value | Volume |
| 97.0¢ | 99.5¢ | 97.0¢ | $974.5K | 992.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 9 | 63027 | 97.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 97.5¢ | 42015 | 24 |
View Market Depth
| Last trade - 11.06am 22/08/2024 (20 minute delay) ? |
| MSB (ASX) Chart |